The technique tests urine and blood serum for common chemicals important to monitoring and treatment of diabetes and cardiovascular, kidney, urinary and other diseases, and lends itself to the development of fast batch testing in hospitals and other clinical settings.
Co-researchers Andrew J. Berger, associate professor of optics, and Dahu Qi, doctoral candidate, used low-refractive-index tubes instead of cuvettes or other bulky containers for holding biological specimens. And, to get more information from the fluids, they used white light—like that from an ordinary light bulb—along with the laser. The tubes and light bulbs made all the difference.
In the laser technique called Raman spectroscopy, scientists shine laser light onto molecules and the light scatters off, gaining or losing energy. A spectrograph translates the changed energies into spectra. Each chemical presents a Raman spectrum that scientists recognize. The Raman approach is a favorite for finding chemicals that overlap and mix in fluid, much like musical instruments in an orchestra. But Raman spectroscopy comes with a problem.
Raman signal is notoriously weak. Using it to test biofluids, with their lighter chemical concentrations than in many fluids, is not a natural choice. Berger and Qi injected fluid samples into a thin transparent tube specially made to contain the light, and the tube's long path length of interaction let the scientists collect more Raman scattering. "The tubes have a refractive index lower than water, so the light bounces along inside the liquid core, just as in solid optical fibers for telecommunications," said Berger. "Other groups had used these fibers to strengthen their Raman signals, so we wanted to see if we could translate that advantage to use with biofluids."
They did get the stronger signal they were looking for, but the increase threw off measurements when samples of urine or blood serum varied in color.
In previous experiments, Berger and his team had explored how a concentration of each chemical relates to the strength of Raman signal. It turned out the relationship is not a simple linear one. They were able to use that information for dealing with differences in sample color.
"We can't neglect that body fluid samples absorb light," said Berger. "We'd have two different samples with the same amount of protein and not get the same strength of signal. If we had two samples of blood serum, maybe one sample would be a little pinker due to a few ruptured red blood cells. Then we wouldn't get the same signal strength."
The solution flashed like a light bulb. The scientists sent a beam of white light through each sample to see how much light was absorbed at various wavelengths, and then they calculated corrections. It was easy enough to inject the light by using the end of the tube opposite the laser. The resulting corrections made chemical predictions significantly more accurate.
The team measured 11 chemicals in blood serum, including total protein, cholesterol, LDL and HDL levels, glucose, triglyceride, albumin, bilirubin, blood urea nitrogen, globulin, and CO2. In urine, they identified urea nitrogen and creatinine. The technique does not measure ions such as calcium or sodium, or other chemicals present at concentrations below about 0.01 mg/mL.
Spectral tests use no chemical reagents and therefore offer the advantage of being nondestructive to fluid samples, unlike many lab tests. After analysis, practitioners could use undamaged samples for other kinds of tests.
"We squeeze a small amount of fluid into the tube," said Berger. "In 10 or 20 seconds, we have a chemical breakdown, and we can see the presence of a lot of chemicals all at once. There's no chemistry performed, and there's no touching of the fluid."
The tubing doesn't just help with the signal strength; it also makes it easy to move biofluids around. "We pump a sample into the tube, pass some light through it, and send it along its way—and then we're all set to pump in the next one," said Berger.
Robert Mooney, professor of pathology and laboratory medicine, collaborated in planning the experiments and arranged for serum and urine specimens from the University of Rochester Medical Center. The Whitaker Foundation provided funding for the research.
Jennifer Wettlaufer | EurekAlert!
What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
06.12.2016 | Materials Sciences
06.12.2016 | Medical Engineering
06.12.2016 | Power and Electrical Engineering